AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18551087
Drug: Sedentary and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedentary and hormone therapy (estradiol valerate 1 mg/d orally)
Trial: 16083524
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 100 mg/kg into the cardiopulmonary bypass prime followed by infusion at 20 mg/kg/h
Trial: 7913854
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg propranolol (PR)
Trial: 42577
Drug: Buccal tablets
RxNorm normalized name: Acyclovir Buccal Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal tablets of demoxytocin
Trial: 26093675
Drug: Standard directly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard directly observed treatment strategy (control).
Trial: 23629959
Drug: CBT‐I with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBT‐I with adjunctive IRT
Trial: 20401752
Drug: Enzymatic hydrolysed
RxNorm normalized name: hydrolysed marine collagen (enzymatic; 2000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzymatic hydrolysed collagen (EHC) 10 g daily
Trial: 20401752
Drug: Glucosamine sulphate
RxNorm normalized name: Glucosamine Sulfate 750 MG Oral Capsule [GLUCOSAMINE SULPHATE]
DrugBank: Glucosamine (DB01296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucosamine sulphate (GS) 1.5 g
Trial: 12790943
Drug: Open treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open treatment (Group A)
Trial: 12790943
Drug: Closed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closed treatment (Group B)
Trial: 9727544
Drug: Isosorbide mononitrate
RxNorm normalized name: Isosorbide Mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide mononitrate (ISMN, 50 mg once daily)
Trial: 7519764
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg panomifene (PAN)
Trial: 7519764
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg panomifene (PAN)
Trial: 7519764
Drug: FSH and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FSH and LH (both doses)
Trial: 3191339
Drug: No heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No heparin (control)
Trial: 31691723
Drug: Curcumin supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin supplementation (500 mg tablet per day)
Trial: 27825697
Drug: Infusional 5‐fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusional 5‐fluorouracil (FU) chemotherapy
Trial: 27825697
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy with irinotecan (IRI)
Trial: 27825697
Drug: Doublet chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doublet chemotherapy (FU + IRI)
Trial: 23510513
Drug: Calcium phosphate
RxNorm normalized name: Calcium Phosphate
DrugBank: Calcium sulfate (DB15533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium phosphate (CaP) supplementation (plus 1 g calcium/d)
Trial: 21216868
Drug: ChimeriVax-WN02 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ChimeriVax-WN02 vaccine
Trial: 18647268
Drug: Spicy meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spicy meal (standard meal mixed with 2 g chili)
Trial: 18647268
Drug: Standard meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard meal with 2 g chili in capsules
Trial: 18647268
Drug: Standard meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard meal with chili capsules
Trial: 9601160
Drug: Ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 800 mg/day
Trial: 9601160
Drug: Codeine 120
RxNorm normalized name: TY-PAP with Codeine 120mg-12mg/5ml Elixir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine 120 mg/day
Trial: 8056992
Drug: Moclobemide (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (450 mg daily)
Trial: 8056992
Drug: Imipramine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (150 mg daily)
Trial: 2658581
Drug: Ciprofloxacin 750
RxNorm normalized name: ciprofloxacin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 750 mg or 1,000 mg twice daily
Trial: 23456769
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 200 μg for 12 weeks
Trial: 23456769
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 400 μg for 12 weeks
Trial: 23456769
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 400 μg compared to 200 μg
Trial: 23456769
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 400 μg compared to 0 μg
Trial: 23456769
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 400 μg
Trial: 17105658
Drug: Primaquine (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primaquine (45 mg single dose)
Trial: 11398582
Drug: Divina (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Divina (2 mg valerate estradiol and 10 mg medroxyprogesterone acetate)
Trial: 9267584
Drug: Trace elements/zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trace elements/zinc 20 mg
Trial: 9267584
Drug: Vitamins (vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamins (vitamin C 120 mg; beta‐carotene 6 mg; alpha‐tocopherol 15 mg)
Trial: 9267584
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of trace elements and vitamins at equal doses
Trial: 8453855
Drug: Felodipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine (10 mg every day)
Trial: 3087688
Drug: Sublingual administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual administration of 1 mg nitroglycerin
Trial: 29505804
Drug: Optimal antidepressant
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal antidepressant monotherapy (imipramine or venlafaxine) for 7 weeks
Trial: 29505804
Drug: Subsequent plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subsequent plasma level-targeted dose lithium addition for 4 weeks
Trial: 29505804
Drug: Subsequent electroconvulsive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subsequent electroconvulsive therapy
Trial: 22431703
Drug: Systemic treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic treatment plus RFA
Trial: 1353540
Drug: Buserelin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buserelin (20 micrograms, administered daily in a nasal spray)
Trial: 1353540
Drug: Human chorionic
RxNorm normalized name: human chorionic gonadotropin
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human chorionic gonadotropin (administered after buserelin treatment)
Trial: 24687848
Drug: Optimally dosed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimally dosed medication
Trial: 18597078
Drug: Bifeprunox 20
RxNorm normalized name: Bifeprunox
DrugBank: Bifeprunox (DB04888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bifeprunox 20 mg
Trial: 18597078
Drug: Bifeprunox (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bifeprunox (5 mg, 10 mg)
Trial: 18597078
Drug: Risperidone 6
RxNorm normalized name: risperidone 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 6 mg
Trial: 16021194
Drug: Oral diazepam,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diazepam, mefenamic acid, acetaminophen (alone or in combination)
Trial: 16021194
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of ketorolac tromethamine
Trial: 14508365
Drug: Itraconazole (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (5.0 mg/kg orally, preoperatively, 2.5 mg/kg orally, two times a day, postoperatively)
Trial: 10961161
Drug: Acarbose (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (100 mg three times per day)
Trial: 8672323
Drug: 10% low‐molecular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% low‐molecular weight (LMW) hydroxyethylstarch solution (HES) in sepsis patients
Trial: 8672323
Drug: 10% low‐molecular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% low‐molecular weight (LMW) hydroxyethylstarch solution (HES) in trauma patients
Trial: 2666205
Drug: benztropine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benztropine (mean dose 3.8 mg)
Trial: 14602
Drug: Propoxyphene napsylate
RxNorm normalized name: Propoxyphene Napsylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propoxyphene napsylate at maximum doses
Trial: 26460660
Drug: Methylprednisolone (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (250 mg at anaesthetic induction and 250 mg at initiation of cardiopulmonary bypass)
Trial: 18296556
Drug: Montelukast 4
RxNorm normalized name: montelukast 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 4 mg oral granules
Trial: 18296556
Drug: Montelukast 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 8 mg once daily for 7 days
Trial: 18296556
Drug: Montelukast 4
RxNorm normalized name: montelukast 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 4 mg once daily for 7 days
Trial: 14739625
Drug: Aspirin combined
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin combined with heparin
Trial: 14739625
Drug: Aspirin combined
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin combined with heparin and ultrasound
Trial: 14739625
Drug: Eptifibatide combined
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eptifibatide combined with aspirin, heparin, and ultrasound
Trial: 14739625
Drug: Tirofiban combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tirofiban combined with aspirin, heparin, and ultrasound
Trial: 10958091
Drug: 3 microg
RxNorm normalized name: Calcitriol 3 microgram/g cutaneous ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 microg x kg(‐1) oral clonidine
Trial: 8769388
Drug: Octreotide 100
RxNorm normalized name: 1 ML octreotide 100 MCG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide 100 micrograms subcutaneously three times daily for 3 to 6 weeks before surgery (group 1)
Trial: 8769388
Drug: Octreotide 100
RxNorm normalized name: 1 ML octreotide 100 MCG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide 100 micrograms subcutaneously three times daily for 3 to 9 months (group 2)
Trial: 8769388
Drug: Octreotide 500
RxNorm normalized name: 1 ML octreotide 500 MCG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide 500 micrograms subcutaneously three times daily (increased dose for incomplete suppression in group 2)
Trial: 8446671
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate 1 mg/kg body weight
Trial: 8446671
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate 2 mg/kg body weight
Trial: 8446671
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate 3 mg/kg body weight
Trial: 8446671
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate 4 mg/kg body weight
Trial: 2946644
Drug: Procaterol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaterol (20 mcg)
Trial: 2946644
Drug: Salbutamol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (200 mcg)
Trial: 25218600
Drug: Memantine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine (20 mg/d after 1 month of titration)
Trial: 19888921
Drug: Melatonin 5
RxNorm normalized name: melatonin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 5 mg (2.5 mg for <6 years)
Trial: 18716362
Drug: Azelnidipine (AZ)
RxNorm normalized name: Azelnidipine
DrugBank: Azelnidipine (DB09230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelnidipine (AZ) 16 mg/d
Trial: 18716362
Drug: Nifedipine-CR (NF)
RxNorm normalized name: nifedipine Extended Release Oral Tablet [Afeditab CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine-CR (NF) 40 mg/d
Trial: 1836066
Drug: Calcium antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonist isradipine
Trial: 28668229
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral dose of probiotics for three weeks or until they gave birth
Trial: 19436282
Drug: AST-120 (spherical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AST-120 (spherical carbon adsorbent) 2-g sachets, oral, thrice a day for 4 weeks
Trial: 17370490
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group treated with medicine
Trial: 15505150
Drug: AVP-923 (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVP-923 (30 mg of DM plus 30 mg of Q) given twice daily for 28 days
Trial: 11218745
Drug: Super-high-flow injection
RxNorm normalized name: Super Spot Remover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Super-high-flow injection method (Group A)
Trial: 11218745
Drug: Conventional injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional injection method (Group B)
Trial: 27842707
Drug: Propofol 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 0.2 mg.kg-1 followed by infusion at a rate of 2 mg.kg-1.h-1
Trial: 27842707
Drug: Ketamine continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine continuous infusion at 0.5 mg.kg-1.h-1
Trial: 19925721
Drug: Night-time sleep
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Night-time sleep facilitating cereal (225 mg tryptophan, 5.3 mg adenosine‐5'‐P, 6.3 mg uridine‐5'‐P per 100 g)
Trial: 19925721
Drug: Night-time sleep
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Night-time sleep facilitating cereal with enriched night milk (480 mg tryptophan, 8.8 mg uridine‐5'‐P, 7.6 mg adenosine‐5'‐P per 100 g)
Trial: 19925721
Drug: Standard cereal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard cereal (75 mg tryptophan/100 g product without nucleotides)
Trial: 16516851
Drug: Monocytes from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monocytes from volunteers with -137G/G genotype
Trial: 9346455
Drug: Self-administered previsit
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered previsit questionnaire
Trial: 29680419
Drug: Green Bright
RxNorm normalized name: acid green 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green Bright Light Therapy (∼507 nm) and Sedentary Activity (sitting, watching TV)
Trial: 29680419
Drug: Green Bright
RxNorm normalized name: acid green 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green Bright Light Therapy (∼507 nm) and Morning Activity (standing, playing motion-sensing videogame)
Trial: 29680419
Drug: Red Light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red Light Therapy (∼643 nm) and Sedentary Activity (sitting, watching TV)
Trial: 29680419
Drug: Red Light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red Light Therapy (∼643 nm) and Morning Activity
Trial: 24997005
Drug: EPA-rich oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA-rich oil capsules
Trial: 24997005
Drug: DHA-rich oil
RxNorm normalized name: Ulkenia DHA oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA-rich oil capsules
Trial: 2173168
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (1 x 1.500 aPTT units plus 2 x placebo injections)
Trial: 2173168
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose conventional heparin (3 x 5.000 IU)
Trial: 2173168
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose conventional heparin
Trial: 699483
Drug: Diazepam (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (30 mg) injected intravenously during uterine contractions (Group I)
Trial: 699483
Drug: Diazepam (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (30 mg) injected intravenously in the relaxation period (Group II)
Trial: 30739558
Drug: Sequential strategy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential strategy (LV5FU2 followed by FOLFOX6)
Trial: 30739558
Drug: Combination strategy
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination strategy (FOLFOX6 followed by FOLFIRI)
Trial: 26390700
Drug: 252Cf neutron
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 252Cf neutron brachytherapy (700‐800 cGy doses at point A, once a week)
Trial: 26390700
Drug: Neoadjuvant intra‐arterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant intra‐arterial embolism chemotherapy (bleomycin, carboplatin, and cyclophosphamide, twice)
Trial: 15713722
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg nandrolone decanoate
Trial: 15713722
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg nandrolone decanoate
Trial: 15713722
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg nandrolone decanoate
Trial: 11921498
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg metadoxine (given intravenously) added to standard treatment
Trial: 9055913
Drug: Growth-promoting treatment
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth-promoting treatment
Trial: 7033015
Drug: Flurbiprofen 100
RxNorm normalized name: flurbiprofen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 100 mg suppository
Trial: 22419369
Drug: rhPTH (1‐34)
RxNorm normalized name: rhPTH
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rhPTH (1‐34) (20 μg, once-daily subcutaneous injection)
Trial: 22419369
Drug: elcatonin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: elcatonin (200 U, once-weekly intramuscular injection)
Trial: 19585577
Drug: Homozygous G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homozygous G allele genotype
Trial: 19585577
Drug: G allele
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G allele
Trial: 15381586
Drug: No intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intravenous access
Trial: 10518849
Drug: Herbal Toothpaste
RxNorm normalized name: Hyperici herba
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal Toothpaste and Gum Therapy
Trial: 8125413
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg Parlodel SRO
Trial: 8125413
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg Parlodel b.i.d.
Trial: 8125413
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg Parlodel SRO (single dose)
Trial: 8125413
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg Parlodel (two doses of 5 mg)
Trial: 70149
Drug: Prednisolone (maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (maintenance dose 15 mg/day)
Trial: 70149
Drug: Corticotrophin (maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticotrophin (maintenance dose 1 mg/week, i.m.)
Trial: 31544345
Drug: Intensive Behavioral
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive Behavioral Therapy (IBT) protocol
Trial: 28623944
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy (MT) that includes spinal manipulative therapy (SMT) plus standardised exercise program
Trial: 23414061
Drug: Mesalazine 1000
RxNorm normalized name: mesalazine 1000 MG Rectal Foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalazine 1000 mg three times daily
Trial: 21675064
Drug: Sedation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedation with propofol infusion (10 to 20 mg x hour), n = 20
Trial: 19368793
Drug: 4microg Trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4microg Trivalent influenza DNA vaccine